Project Grant R01GM160384
- Federal Grant Award Summary The University of Utah received a $423,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 5, 2025, through July 31, 2030. This five-year research initiative delivers fundamental scientific investigation into the mechanisms of compartmentalized signaling in electrically excitable cells, specifically examining how electrical signals in neurons...
- Federal Project Grant Award Summary The University of Utah received a $500,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 2, 2026, with completion by December 31, 2030. This five-year research initiative focuses on developing and applying nicotinic acetylcholine receptor (nAChR) targeted peptides for biomedical research. The primary deliverables include: (1) creation of a...
- Federal Project Grant Award Summary The University of Connecticut Health Center received a $457,875 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 15, 2026, with a completion date of January 31, 2031. This five-year research initiative focuses on elucidating the molecular mechanisms of cell migration through investigation of microtubule post-translational modifications,...
- Federal Project Grant Award Summary The University of Utah's Office of Sponsored Projects received a $423,500 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) effective April 1, 2026, with completion by January 31, 2031. This award funds fundamental research investigating the biological functions, biosynthesis, and dynamic regulations of RNA chemical modifications. The research addresses three key...
- Federal Grant Award Summary The University of Utah received a $423,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, through December 31, 2030. This five-year research project focuses on elucidating the molecular mechanisms of divergent acyl carrier protein (ACP) functions at the intersection of mitochondrial and apicoplast metabolism in Plasmodium...
- Federal Grant Award Summary The University of Utah received a $423,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025 through June 30, 2030. This Maximizing Investigators' Research Award (MIRA/R35) consolidates multiple research initiatives into a comprehensive investigation of post-translational modification (PTM)-driven cell signaling mechanisms with...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Georgia Research Foundation, Inc. a Project Grant of $189,854.00 under the Biomedical Research and Research Training program (CFDA 93.859) effective August 8, 2025, with a completion date of July 31, 2028. This award supports research to unravel the connection between cell deformability and motility in eukaryotic cells through development of an integrated in vitro and computational...
- Federal Grant Award Summary The University of Nebraska Board of Regents received a $2.04 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with completion targeted for July 31, 2029. This award supports fundamental research investigating the ARP2/3 complex—a critical protein assembly system essential to cellular processes including cell migration, tissue...
- Federal Project Grant Award Summary The University of Chicago received a $1.9 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. This award funds fundamental research investigating the molecular basis and regulation of myosin-10, a specialized motor protein critical to cellular transport and motility. The research integrates...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $158,240 to the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) with an award date of March 5, 2026, and completion date of November 30, 2027. This grant supports fundamental biomedical research investigating the mechanical properties of cell-cell adhesion, specifically examining how E-cadherin clusters regulate the...
The University of Utah received a $392,942 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 22, 2026, with a completion date of February 28, 2030. This grant supports fundamental biomedical research investigating the regulation of single cell migration in vivo, with a specific focus on understanding focal adhesion dynamics during cell migration in living organisms. The research employs an innovative visualization system utilizing zebrafish larval skin to directly observe focal adhesion formation and behavior in migrating cells—a significant departure from traditional two-dimensional and three-dimensional in vitro culture models that have historically dominated migration studies. The project addresses a critical gap between laboratory-based findings and in vivo cell behavior by examining how focal adhesion components, particularly paxillin phosphorylation, regulate cell migration in living systems. The research outcomes are intended to enhance understanding of fundamental biological processes governing cell migration and establish a foundation for advances in disease diagnosis and treatment, particularly for conditions such as cancer where aberrant cell migration plays a critical role. The award supports the research team's ability to develop and validate new mechanistic insights into focal adhesion biology that may inform future pharmaceutical development targeting focal adhesion machinery for therapeutic intervention.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $392.9k | 5/26/26 |